Viewing nowCombinationCandecanduo Tablets 10/8 mg
Rosuvastatin Calcium 10.4mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.

MFDS item code 202107120 · Approved 2021.10.25 · Insurance code 694003670
Treatment of hypertension and heart failure; improvement of hyperlipidemia; inhibition of atherosclerosis progression and cardiovascular risk
This medication is used for patients who need to take both Candesartan Cilexetil and Rosuvastatin simultaneously. Candesartan Cilexetil is used in the treatment of essential hypertension and heart failure (especially in patients with impaired left ventricular systolic function who require add-on therapy to ACE inhibitors or have poor tolerability). Rosuvastatin is used as an adjunct when dietary changes and exercise are insufficient to control hyperlipidemia and dyslipidemia and is also helpful in the treatment of familial hypercholesterolemia and primary dysbetalipoproteinemia. Additionally, it effectively lowers total cholesterol and LDL cholesterol levels, slowing the progression of atherosclerosis, and reduces the risk of stroke, myocardial infarction, and arterial revascularization in patients with elevated high-sensitivity C-reactive protein levels who are at high cardiovascular risk. Thus, the combination of Candesartan Cilexetil and Rosuvastatin manages both hypertension and dyslipidemia, improving cardiovascular health.
This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of each component, candesartan cilexetil and rosuvastatin. ○ Candesartan cilexetil 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatments should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Elderly patients: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: In patients at increased risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: An initial dose of 4 mg once daily is recommended. The dose may be doubled at intervals of 2 weeks or more and increased to a maximum of 32 mg once daily, taking the patient's tolerability into consideration. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No adjustment of the initial dose is necessary. ○ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 mg once daily; if a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or more according to LDL cholesterol levels, treatment goals, and the patient's response, and may be increased to a maximum of 20 mg once daily. 2. Elderly patients: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution is required when administering 20mg of this medicine to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function tests should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose is contraindicated in some of these patients. Patients taking candesartan cilexetil and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.
Adolescents and children 18 years of age or younger: Safety and efficacy have not been established. Adolescents and children 18 years of age or younger: Safety and efficacy have not been established.
This medication can be very dangerous for the fetus during pregnancy, so it must be discontinued immediately if pregnancy is confirmed. Patients with allergies to this medication or those with liver disease, severe kidney impairment, myopathy, or hereditary angioedema should not take it. Elderly patients, those with liver dysfunction, and patients with hyperkalemia should use this drug cautiously, and regular blood tests and physical condition checks are necessary. If symptoms of muscle pain or weakness occur, consult a doctor immediately, and treatment should be discontinued in severe cases. This medication may affect liver function, so regular liver function tests should be performed both before and during treatment. Drug interactions may occur, so inform your doctor or pharmacist of any other medications you are taking. This medication may cause dizziness when driving or operating machinery, so caution is advised. Keep this medication out of the reach of children and do not transfer it to another container.
Headache, nasopharyngitis, local infection, fatigue, generalized pruritus, dermatitis, itching, joint stiffness, limb pain, photophobia, dyspepsia, elevated blood sugar, decreased serum sodium, hand fracture, hypoglycemia, nephrolithiasis, cough, headache, itching, nausea, dizziness, orthostatic dizziness, meibomian cyst, periodontal disease, inflammation, foreign body sensation, chest discomfort, musculoskeletal pain, neck pain, cataract, elevated blood sugar, decreased serum sodium, hand fracture, hypoglycemia, nephrolithiasis, cough, rash, urticaria, myalgia, myopathy, rhabdomyolysis, asthenia, fever, paresthesia, dyspepsia, gastroenteritis, tachycardia, palpitations, increased creatine kinase, hyperglycemia, hypertriglyceridemia, hyperuricemia, epistaxis, anxiety, depression, somnolence, dyspnea, hematuria, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, eosinophilia with systemic symptoms drug reaction syndrome, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, paralysis, hypertonia, syncope, facial flushing, weight gain, facial edema, thirst, decreased libido, amnesia, loss of appetite, increased appetite, tinnitus, taste disturbance, erectile dysfunction, dizziness, orthostatic dizziness, nausea, arthralgia, myalgia, low back pain, increased blood pressure, cerebral infarction, spondyloarthritis, musculoskeletal discomfort, pneumonia, femoral fracture, contusion, unstable angina, idiopathic pulmonary fibrosis, productive cough, worsening hypertension, unstable blood pressure, vertigo, orthostatic vertigo, adrenal insufficiency, acute renal failure, shock, syncope, loss of consciousness, intestinal vascular edema, interstitial pneumonia, thrombocytopenia, increased serum creatinine, joint pain, numbness, sensory disturbance, chest discomfort, abdominal pain, diarrhea, loss of appetite, abdominal distension, muscle cramps, gout
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. Also, it should be stored at room temperature between 1 degree and 30 degrees Celsius to maintain its effectiveness.
Pink round film-coated tablet
30 tablets/box [10 tablets/PTPX3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
AlboGen Korea Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Candesartan Cilexetil 32mg
Tablet · Prescription medication · Combination
Albogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 16mg
Tablet · Prescription medication · Combination
Alvogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Alvogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 16mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.